Dry powder formulation of caveolin-1 peptides and methods of use thereof

US12280089B2 · kind B2 · utility

Assignees

• The Board of Regents of the University of Texas System · US
• Rein Therapeutics, Inc. · US

Inventors

• Robert O. WILLIAMS, III · Austin, US
• Alan B. Watts · Plainsboro, US
• Yajie Zhang · Fuzhou, CN
• Sawittree SAHAKIJPIJARN · Austin, US
• Dale J. Christensen · Cary, US
• John J. Koleng · Austin, US
• Sreerama SHETTY · Tyler, US

Key dates

• Filing date: Feb 6, 2024
• Grant date: Apr 22, 2025
• Expiry date: Feb 6, 2044

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are compositions comprising caveolin-1 (Cav-1) peptides. Further provided are methods of using the Cav-1 peptides for the treatment of lung infections or acute or chronic lung injury, particularly lung fibrosis.